Associate Professor of Medicine, SUNY Upstate Medical University, United States
Profile
Scopus
Short Bio
Dr. Alina Basnet is an accomplished Assistant Professor of Medicine at SUNY Upstate Medical University in the Division of Hematology Oncology. She is a dedicated clinician and educator with extensive experience in internal medicine and oncology, contributing significantly to the field through her clinical practice, research, and teaching.
Education 🎓
Dr. Basnet earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Kathmandu University, Nepal (2003-2009). Prior to medical school, she completed her higher secondary degree at St. Xavier’s Campus, Tribhuvan University, Nepal (2001-2003). Her postgraduate training includes an Internal Medicine Residency at Seton Hall University (2012-2015) and a Hematology-Oncology Fellowship at SUNY Upstate Medical University (2015-2018).
Experience 💼
Dr. Basnet serves as the Fellowship Program Director for the Division of Hematology Oncology at SUNY Upstate Medical University since June 2023. She has also been a Clinical Assistant Professor in the Department of Internal Medicine since 2018. Previously, she was the Quality Officer for the division and has held various clinical and academic positions in Nepal and the United States.
Research Interests 🔬
Dr. Basnet’s research focuses on genitourinary cancers, clinical outcomes in oncology, and the role of tumor mutational burden in therapeutic response. She has been a principal investigator in several clinical trials and actively collaborates with national cooperative oncology groups.
Awards and Honors 🏆
Dr. Basnet has been recognized with several awards, including the Intern of the Year (2012-2013) and travel awards to major conferences like ASCO and the Hematology Fellows Consortium. She also received invitations to present at regional and national oncology meetings.
Publications 📚
- Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma with Elevated Tumor Mutational Burden
- Necchi A, Spiess PE, Costa de Padua T, Li R, Grivas P, Huang RSP, Lin DI, Danziger N, Ross JS, Jacob JM, Sager RA, Basnet A, et al.
- JAMA Netw Open (2023), cited by 38 articles.
- PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients with High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer
- Aggarwal R, Heller G, Hillman DW, Xiao H, Picus J, Taplin ME, Dorff T, Appleman L, Weckstein D, Patnaik A, Basnet A, et al.
- J Clin Oncol (2024), cited by 12 articles.